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The antigenic analysis of the structural proteins specified by C-type RNA viruses 
has been advanced in recent years. The presence of an interspeeies cross-reacting anti- 
genie determinant associated with an intraspecies antigenic determinant of the struc- 
tural proteins of mammalian C-type RNA viruses was first described by Geering et al. 
(1, 2). The interspecies cross-reacting determinant of mammalian C-type RNA viruses 
has become increasingly important for the  search and the analysis of  C-type RNA 
viruses in other species, especially in man. The protein containing  these  antigenic 
determinants has been purified in several laboratories and shown to be a major internal 
polypeptide of mammalian C-type RNA viruses with a tool wt of about 30,000 daltons 
(3-6), being termed p  30 by the consensus of participants in an oncogenie RNA virus 
meeting held in June,  1973, at Memorial Sloan-Kettering Cancer Center, New York. 
The antigens of p  30 protein have  been  termed gs-1,1 intraspeeies (species specific) 
determinant,  and gs-3, interspeeies cross-reacting determinant (1,  2).  gs-1 and  gs-3 
were proved to be on the same molecule of p  30 protein (7-9). Two other interspeeies 
cross-reacting antigenic determinants of mammalian C-type RNA viruses have been 
demonstrated recently: (a) RNA-dependent DNA polymerase of mammalian C-type 
RNA viruses (10,  11), and (b) the viral envelope glycoprotein component with a mol 
wt of 69,000-71,000 daltons (12,  13). 
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1  Abbreviations uzed in this paper: FeLV, feline leukemia virus; gs, group specific; gs-1, in- 
traspecies (species specific) determinant; gs-3, interspecies cross-reacting determinant; IFA, 
immunofluorescence absorption test; MuLV, murine leukemia virus; PBS, phosphate-buffered 
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strain of MuLV; RSV-2, Rous sarcoma virus; SSV, simian sarcoma virus; ST-FSV,  Snyder- 
Theilen strain of feline sarcoma virus. 
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In recent work undertaken  in  this laboratory  an  antibody  which recognizes 
a  common ceil surface antigen  associated with murine  and feline C-type RNA 
viruses was  demonstrated  by  the use  of rabbit  antiether  disrupted  feline leu- 
kemia virus (FeLV)  antiserum  and the indirect membrane immunofluorescence 
method  (14).  We now present  data which establish  that  the common cell sur- 
face antigen is membrane-bound  group-specific (gs)  antigen bearing the identi- 
cal gs determinant  known  to  be shared  by mammalian  C-type  RNA  viruses. 
The possible biological properties of membrane-bound  gs antigen  are  also dis- 
cussed. 
Materials and Methods 
Mice.--AKR/J and C57BL/6J mice were purchased from Jackson Laboratories, Bar Har- 
bor, Maine. These mice were maintained in a specific pathogen-free environment. 
Leukemia.s and  Tumors.--Mice bearing spontaneous or induced, autologous or transplant- 
able, leukemias and  tumors were available in our laboratory or supplied by Dr. L. J.  Old 
(Sloan-Kettering Institute for Cancer Research, New York).  Specimens of feline and canine 
lymphomas were obtained from fresh autopsy materials. Fresh specimens of human leukemias, 
sarcomas,  and  other  neoplasms  were  obtained  from  the  surgical  and  medical services of 
Memorial Hospital, Sloan-Kettering Institute for Cancer Research, New York, as they became 
available through standard therapeutic and diagnostic procedures. 
Tissue  Culture Lines.--Cultures of chicken, hamster,  rat, feline, canine,  bovine, porcine, 
and  human  cells with or without  infection by avian and  feline C-type RNA viruses,  and 
woolly monkey tumor cells producing woolly monkey sarcoma virus were obtained from Dr. 
P.  S.  Sarma  (National  Cancer  Institute,  Bethesda,  Md.,  under  contract  NIH-No.l-43254 
of the Virus Cancer Program).  Cultures of an epitheloid cell line derived from a  rat leuke- 
mia (RRTC) induced  by Rauscher strain of murine leukemia virus (MuLV),  and  of cat fi- 
broblasts infected with FeLV were from our laboratory (4, 15). 
Subviral Proteins of C-Type RNA  Viruses.-- 
Crude viral proteins  of mammalian  C-type RNA  viruses:  Crude  viral proteins were pre- 
pared from concentrated suspensions  of Rauseher strain of MuLV, Rickard strain of FeLV, 
and  SSV-1 strain of simian sarcoma virus (SSV). The virus suspensions  were prepared from 
isolated viruses recovered from the media of cultured cells by zonal ultracentrifugation fol- 
lowed by pelletization, and  final suspensions  contained  more than 101° virus particles/ml. 
FeLV was derived from Rickard-F-422 cat thymus leukemia line and SSV-1 was derived from 
SSV-1-HF infected marmoset tumor cell line (16). The virus suspensions  were supplied through 
the courtesy of Dr. J.  Gruber  (National Cancer Institute,  Bethesda,  Md.).  Each virus sus- 
pension was frozen-thawed twice and sonicated for 60 s in an ice bath. The clear supernate 
was recovered by centrifugafion at 10,000 rpm for 30 rain and was used as crude viral proteins 
of C-type RNA viruses. 
Subviral fractions  of MuLV and FeLV isolated by gel filtration  in guanidine  hydrochloride 
(GuHCl):  Six subviral proteins were isolated and prepared by preparative  gel filtration in 
GuHC1 from Rauseher leukemia virus and FeLV derived from our own culture fines according 
to the method described by Nowinski et al. (4). Pellets of virus previously banded by density 
gradient centrifugation on a sucrose gradient (15-60%) were suspended in saturated GuHC1, 
2% mercaptoethanol, and 10% sucrose,  pH 8.6.  Samples were heated at 100°C for 3 min and 
were then layered upon an agarose column (Bio Gel A-5 mm 200--400 mesh, Bio-Rad Labora- 
tories, Richmond, Calif.) Column buffer was 6 M  GuHC1 with 0.01 M dithiothreitol, pH 6.5. 
Column was run at room temperature at a flow rate of 1.5 ml/h. Six peak fractions of C-type 
viral protein were dialyzed free from GuHC1 and dithiothreitol and stored at -- 70°C until use. 
p 30 protein  of MuLV and FeLV purified  by isoelectric focusing:  Isoelectric-focused p 30 
protein of MuLV and FeLV were kindly supplied by Doctors R. V.  Gilden and S. Oroszlan YOSHIKI~  MELLORS~  HARDY~ AND  FLEISSNER  927 
(Flow Laboratories, Inc., Rockvilie,  Md.).  The method of preparation was  fully described 
elsewhere (5, 9). 
Antisera.--The following antisera were used for the present study. 
Rabbit anti-FeLV:  Rabbit anti-FeLV antiserum was  produced  by  immunizing rabbits 
with ether-disrupted FeLV. The purified FeLV banded by density gradient centrifugation on a 
sucrose gradient was disrupted with ether, mixed with Fretmd's adjuvant, and injected sub- 
cutaneously at several sites (17). 
Rabbit anti-FeLVp 30:  Rabbit anti-FeLVp 30 antiserum was produced  by  immunizing 
rabbits with FeLVp 30, the third protein fraction eluted from GuHCl-disrupted FeLV by gel 
filtration and known to be gs protein. The immunizing schedule was the same as described 
above. 
Rabbit and anti-MuLVp 30:  Rabbit anti-MuLVp 30 antiserum was produced in rabbits 
with MuLVp 30 prepared from GuHCl-disrupted Rauscher leukemia virus by gel filtration. 
The immunizing schedule was described above. 
All antisera were heat inactivated at 56°C for 30 rain and were stored at -70~C until use. 
The unabsorbed antisera contained antibodies against normal cellular components of mouse 
tissues. The antisera were absorbed in vitro with C57BL/6J spleen and thymus cells in order 
to remove these antibodies. Procedures of preliminary absorption were fully described in a 
previous paper  (14).  The antisera were  titrated against viable EoZG2 cells by the indirect 
membrane immunofluorescence test by doubling dilutions, and the fluorescent end point (50% 
fluorescent cells)  was determined. 
Membrane Immunofluorescence Test.--The  indirect immunofluorescence test with  viable 
cells was carried out as described by Aoki et al.  (18) with slight modification. The standard 
target cells were transplanted leukemia EoZG2 originally induced in C57BL]6 mouse by pas- 
sage A Gross virus (19).  Suspensions of viable EoZG2 cells were prepared from the spleens of 
C57BL/6J mice bearing transplants of E~G2 as described previously (20).  A mixture of 50 
/zl of antiserum at a certain dilution and 25 #1 of cell suspension (4 X  107/ml) was incubated 
at 4°C for 30 rain with occasional shaking. The cells were then washed twice with medium 199 
(Microbiological Associates, Inc., Bethesda, Md.) in the cold and suspended in 50 #1 of fluo- 
rescein-conjugated goat antiserum to rabbit 7S -g-globulin (Hyland Div., Travenol Labora- 
tories, Los Angeles, Calif.) at a dilution of 1 : 15. Mter incubation for 30 rain at 4°C, the cells 
were finally washed twice with medium 199, suspended in 50% glycerol in 0.01  M  phosphate- 
buffered (pH 8.0) isotonic saline (PBS), and examined under a cover slip with a Zeiss fluores- 
cence microscope  (exciter filter BG12,  barrier filters 50 and 44,  and dark field condenser) 
(Carl Zeiss, Inc., New York). Negative controls were either medium 199 alone or normal rabbit 
serum and both were virtually unstained. 
Immunofluorescence Absorption Test (IFA).--Washed cells and tissue homogenates  to be 
tested were transferred into small glass tubes (6  X  50 ram)  and centrifuged  for 10 rain at 
2,000 rpm.  Equal volumes of washed cells,  tissue homogenates, or protein preparations and 
the antiserum diluted two tubes below the fluorescent end point (50% fluorescent ceils)  were 
incubated for 60 rain at 4°C with constant shaking. Mter centrifugation for 15 rain at 2,000 
rpm,  the supernatant fluids at  1:1 and  1:2 dilutions were tested for the residual  antibody 
activity on viable EcVG2 cells by the indirect membrane immunofluorescence test. Prepara- 
tion of cells and tissue homogenates were described (20). 
The Indirect Immunofluorescence Test on  Cryostat Seaions.--In  order  to  demonstrate gs 
antigen in the cytoplasm  of cells,  the indirect immunofluorescence  test was performed  on 
cryost~t sections of C57BL/6J mouse spleens bearing Ec~G2 transplant.  The sections were 
air dried,  fixed in acetone for 30  rain,  and  washed  twice in PBS  (pH  7.6).  The sections 
were incubated at room temperature for 35 rain with rabbit anti-MuLVp  30 and FeLVp 30 
antisera, followed by washing with PBS and treatment with fluorescein-conjugated goat anti- 
serum to rabbit 7S "y-globulin diluted 1:30. The fluorescent antibody was previously absorbed 
with mouse "y-globulin (Miles Laboratories, Inc., Miles Research Div., Kankakee, Ill.). 928  CELL  MEMBRANE-BOUND  gs  ANTIGEN 
Immunoetectron Microscopy.--lO X  106 washed viable cells were incubated  for 30 rain in 
0.2 ml of a  1:5 dilution of rabbit anti-FeLVp 30 antiserum. Mter two washings, the cells were 
resuspended in 0.2 ml of ferritin-conjugated sheep antibody to rabbit ),-globulin. Mter further 
incubation for 30 rain, the cells were washed twice. The final pellets were covered with 2 ml of 
2% glutaraldehyde for 40 min. After postfixation for 60 min in 1%  osmium tetroxide,  the 
pellets were left overnight in 2% uranyl acetate. The next morning, they were dehydrated 
progressively in 70, 95, and 100% ethanol. All procedures were carried out at 4°C except for 
dehydration in  100%  ethanol at  room  temperature.  They were  embedded  in Epon  (Shell 
Chemical Co., New York) as usual. Thin sections were cut on a Sorvall MT-2 ultramicrotome 
(Ivan SorvaU,  Inc., Norwalk, Conn.) with a diamond knife, stained with 0.5% uranyl acetate 
in alcoholic solution and lead citrate, and examined with a  Siemens Elmiskop IA electron 
microscope (Siemens Corp., Medical Industrial ])iv., Iselin, N. J.). Ferritin-conjugated sheep 
antibody to rabbit T-globulin was a generous gift of Dr. K. C. Hsu (Columbia University, New 
York)  and was  extensively absorbed with C57BL/6J  spleen and thymus cells,  and EoZG2 
cells. 
RESULTS 
Demonstration  of Common Cell Surface  Antigen Associated with Mammalian 
C-Type RNA  Viruses in the Tissue-Cultured  Cells Infected  or Trl nsformed  by 
C-Type RNA  Viruses.--In  the previous communication  (14),  a  new common 
cell  surface  antigen  associated  with  murine  and  feline C-type RNA  viruses 
was demonstrated in all leukemias of mice tested: in normal lymphoid tissues 
of Gross-positive (high incidence of leukemia) mouse strains AKR, AKR/H-25, 
C58,  and NZB; in  cultured rat fibroblasts infected with MuLV; in  cultured 
feline fibroblasts infected with FeLV; and in spontaneous feline lymphosarcoma 
by the IFA with  rabbit  anti-FeLV antiserum  as described in  Materials  and 
Methods. We extended the investigation with various cultured cells infected or 
transformed by C-type RNA viruses and examined for the expression of com- 
mon cell surface antigen as determined by the IFA with rabbit anti-FeLV anti- 
serum (Table I). Antiserum diluted to 1:20, two tubes below end point (50% 
fluorescent-positive cells), was absorbed with the cultured cells listed in Table I, 
and  the residual  antibody activity of  the recovered serum was  titrated both 
undiluted and at 1 : 2 dilution against viable Ec~ G2 cells by the indirect immu- 
nofluorescence test. Embryo feline fibroblasts infected with various subgroups 
of FeLV  or  transformed  by  Snyder-Theilen  strain  of  feline sarcoma  virus 
(ST-FSV), feline fibroblasts infected with FeLV  (our own strain),  and RRTC 
cells absorbed  the  antibody  activity  from  the  antiserum.  Hamster, canine, 
porcine, bovine, and human embryo cells infected or transformed by ST-FSV 
equally  absorbed the antibody activity. No trace of  the antigen was demon- 
strable  in  comparable  homologous  normal  cells,  chickeu  cells  transformed 
by Rous sarcoma virus (RSV-2), or woolly monkey tumor cells producing woolly 
monkey sarcoma virus. 
Search for Common Cell Surface  A nhgen in  Various  Mammalian Leukemias 
and Tumors.--Neoplastic tissues of mouse, cat, dog, and human were examined 
for the expression of common cell surface antigen by the IFA with rabbit anti- 
FeLV antiserum  (Table II).  Common cell surface antigen was demonstrable YOSHIKI~ ~ELLORS~  HARDY~ AND  ~LEISSNER  929 
TABLE I 
Demonstration of Common Cell Surface Antigen in Cultured Cells Infected or Transformed by 
Mammalian C-Type RAVA Viruses 
Cells used for absorption 
Residual antibody 
activity* 
Result 
Dilution  of 
of absorbed  absorp- 
serum  tion 
1:1  1:2 
Uninfected feline embryo fibroblasts 
Feline embryo fibroblasts infected with FeLV, subgroup AS 
Feline embryo fibroblasts infected with FeLV, subgroup B 
Feline embryo fibroblasts infected with FeLV, subgroup C 
Feline embryo fibroblasts transformed by ST-FSV¶ 
Feline fibroblasts infected with our own FeLV 
%  % 
73  65  - 
<10  <10  + 
<10  NT§  + 
39  NT  + 
<10  <10  + 
<10  <10  + 
80  71 
Uninfected canine embryo fibroblasts 
Canine embryo fibroblasts transformed by ST-FSV 
Uninfected whole porcine embryo cells 
Whole porcine embryo cells transformed by ST-FSV 
Uninfected whole bovine embryo cells 
Whole bovine embryo cells transformed by ST-FSV 
Uninfected whole human embryo cells 
Whole human embryo cells infected with ST-FSV 
75  NT  -- 
< 10  NT 
NT  52  - 
<10  <10  + 
72  55  -- 
NT  < 10 
NT  54  - 
NT  <10  -[- 
84  79 
Uninfected chicken cells 
Chicken ceils transformed by RSV-2 
Hamster ceils transformed by  ST-FSV 
81  NT  -- 
79  NT  -- 
19  < 10  + 
86  77 
Uninfected rat fibroblasts 
RRTC ceils producing Rauscher virus 
65  NT  -- 
15  <10  -b 
76  49 
Woolly monkey cells producing WMSV¶  75  69 
87  76 
* % fluorescent-positive cells. 
FeLV, feline leukemia virus (see reference 31). 
§ NT, not tested. 
¶ WMSV, woolly monkey sarcoma virus. 
in  all  murine  leukemias,  spontaneous  or  induced,  and  all  spontaneous  cat 
lyraphosarcomas.  Two plasma cell tumors  and a  mammary  tumor of mice  and 
normal lymphoid tissues of cat were negative for the expression of the  antigen. 
The common cell surface  antigen  was  not found  in  any  canine  or human  na- 
turally occurring lymphoid or nonlymphoid  tumors. 930  CELL  MEMBRANE-BOUND gs ANTIGEN 
TABLE II 
Occurrence of Common Cell Surface A ntlgen in Tumor Ceils of Various Species 
Species  Tumor  Result~ 
Mouse*  Leukemia, spontaneous  9/9 
Leukemia, induced  5/5 
Mammary tumor  0/1 
Myeloma  0/2 
Cat  Spontaneous lymphosarcoma 
Normal lymphoid  tissues 
4/4 
O/4 
Dog  Spontaneous lymphosarcoma  0/1 
Human  Chronic lymphatic leukemia  0/7 
Acute monocytic  leukemia  0/2 
Hodgkins sarcoma  0/6 
Osteogenic sarcoma  0/3 
Carcinoma  0/5 
* See reference 14. 
Number positive/number examined  by IFA. 
Demonstration of Common Cell Surface Antigen in Subviral Proteins of MuL V 
and  FeLV Prepared  By  Gel  Filtration in  GuttCl  and  Isoelectric  Focusing.- 
Since the antiserum detecting common cell surface antigen was produced by 
immunizing rabbits  with  ether-disrupted  FeLV, it is  reasonable  to  suppose 
that common cell surface antigen is related to, or indentical with, some struc- 
tural protein of C-type RNA virus. We examined this possibility by using the 
IFA  of  rabbit  anti-FeLV antiserum with  sonicated  crude  viral  proteins  of 
MuLV, FeLV, and SSV; with six isolated subviral proteins of MuLV prepared 
by gel filtration in GuHC1; and with p 30 protein of MuLV and FeLV purified 
by isoelectric focusing. The residual antibody activity of the above was tested 
on E c~ G2 cells by the indirect membrane immunofluorescence test (Table III). 
Common cell surface antigen was demonstrable equally in crude viral proteins 
of MuLV and FeLV; in contrast, crude viral protein of SSV did not show de- 
monstrable  absorption.  Of  six  subviral  proteins  of  MuLV  prepared  by  gel 
filtration in GuHCI, only p 30 protein, the third protein fraction eluted and the 
fraction  known  to  contain  gs-1  and  -3  antigenic  determinants,  completely 
absorbed  the  antibody activity from the  antiserum. The  other five protein 
fractions were virtually negative for the absorption except gp 45 (void volume 
fraction) which showed weak absorption. These results were confirmed by the 
IFA with purified MuLVp 30 and FeLVp 30 protein prepared by isoelectric 
focusing; purified gs antigen of both MuLV and FeLV equally absorbed the 
antibody activity against common cell surface antigen from rabbit anti-FeLV 
antiserum. These findings strongly indicate that common cell surface antigen YOSHIKI, MELLORS, H.KRDY, AND  FLEISSNER  931 
TABLE HI 
Demonstration of Common Ceil Surface AntCgen in Structural Proteins of Mammalian C-Type 
RNA  Viruses 
Antigens used for absorption 
Residual  antibody  activity* 
Dilution  of absorbed  serum  Result of  absorption 
1:1  1:2 
Exp. 1: Crude viral proteins 
Sonicated MuLV  < 10%  < 10%  + 
Sonicated FeLV  17  < i0  + 
Sonicated SSV  73  66  -- 
--  76  69 
Exp. 2: Subviral proteins of MuLV prepared 
by gel filtration 
gp 45 (50 #g)§  71  58:~ 
gp 70 (40 #g)  78  65 
p 30 (20 ug)  <lO  <lO 
p 15 (30 #g)  72  62 
p 12 (20 #g)  77  6t 
p 10 (30/zg)  76  63 
--  79  65 
Exp. 3: gs antigen purified by isoelectric 
focusing 
MuLVp 30 (20 #g)  <10  <10  + 
FeLVp  30 (20/zg)  10  <10  + 
91  85 
-  (±) 
+ 
* % fluorescent positive cells. 
Weak fluorescence reaction. 
§ Parentheses indicates #g protein used for absorption of 50 #1  of antiserum.  Rabbit 
anti-FeLV antiserum two tubes below end point (50%  fluorescent-positive  cells) were ab- 
sorbed with viral proteins at 4°C overnight, and residual antibody activity was titrated at 
1:1  and  1:2 dilution of recovered  serum against ECG2  cells by the membrane immuno- 
fluorescence test. 
is indeed related to a known viral structural component of mammalian C-type 
RNA  viruses  and  identical with  gs-3  antigen  known  to  be  shared  by mam- 
malian  C-type RNA  viruses. 
Indirect Membrane Immunofluorescence Reaction with Rabbit Anti-FeL Vp 30 
Antiserum.--To confirm these results, the rabbit antiserum against purified p 30 
protein of FeLV which contains only specific antibodies to gs antigen was ex- 
amined  by  the  indirect  membrane  immunofluorescence  test  to  determine 
whether it contained interspecies cross-reacting antibody reacting with viable 
EC G2 cells. After in vitro absorption with C57BL/6J  tissues as described in 
the  Materials  and  Methods,  the  antiserum  reacted with  the  cell  surface  of 
E C G2. The  fuorescence end point  (50%  fluorescent-positive cells) was  at  a 932  CELL  MEMBRANE-BOUND  gs  ANTIGEN 
serum dilution of 1:80, which closely parallels the titer found against acetone- 
fixed E o  z G2 cells. 
The  Specificity  of  the  Indirect  Membrane  Immunofluorescence  Reaction of 
E~G2 Cells with Rabbit Anti-FeLVp 30 Antiserum.--In order to demonstrate 
the specificity of the antibody, the antiserum diluted two tubes below the fluo- 
rescence end point was absorbed with various tissues, cultured cells, and purified 
subviral proteins of mammalian C-type RNA viruses listed in Table IV. The 
absorbed antiserum was tested for the residual antibody activity against viable 
E o  z G2 cells by the indirect membrane immunofluorescence test. Lymphoid tis- 
sues of AKR/J mice absorbed the antibody activity, whereas no absorption 
(except sometimes weak absorption with bone marrow and spleen cells) was 
observed with comparable C57BL/6J tissues. The antigen was demonstrated 
in all mouse leukemias so far assayed but was not demonstrable in a transplant- 
able myeloma. Cultured feline fibroblasts infected with FeLV and RRTC cells 
producing  Rauscher  virus  equally  absorbed  the  antibody  activity.  By  the 
method employed, no  trace of the  antigen was  demonstrable in comparable 
homologous cells or in woolly monkey tumor cells producing woolly monkey 
sarcoma virus. Crude viral proteins of MuLV and FeLV equally absorbed the 
antibody activity, whereas those of SSV did not. p  30 protein of MuLV iso- 
lated  by  gel  filtration  in  GuHC1  strongly  absorbed  the  antibody  activity, 
whereas gp 45 protein of MuLV did not. Isoelectric-focused p  30  protein of 
MuLV and FeLV absorbed antibody activity from rabbit anti-FeLVp 30 anti- 
serum. It was concluded that the antibody specificity of rabbit anti-FeLV and 
rabbit anti-FeLVp 30 antiserum against viable EoZG2 cells was virtually the 
same and, again, that the antigen demonstrated on the cell surface by rabbit 
anti-FeLVp 30 antiserum was gs-3  determinant of mammalian  C-type RNA 
viruses. 
Demonstration of gs-1 Determinant of MuLV on the Surface of Cells.--Since 
Gilden et al.  and Oroszlan et al.  (7-9) presented evidence that gs-1  and gs-3 
antigenic  determinants  are  present  on  the  same  protein  molecule,  it  was 
reasonable in our work to ask whether gs-1,  the intraspecies (species specific) 
antigenic determinant of mammalian C-type RNA viruses, is also present on 
the surface of cells. We examined this possibility by using rabbit anti-MuLVp 
30 antiserum which contained specific antibody to gs-1 determinant of MuLV. 
Viable E o  ~ G2 cells were used as target cells in the indirect membrane immuno- 
fluorescence test. After in vitro absorption with  C57BL/6J  tissues,  the  anti- 
serum was found to contain antibody that reacted with viable E o  ~ G2 cells by 
the membrane immunofluorescence test. The fluorescence end point was at a 
serum dilution of 1:640, in close parallel with the titer against  acetone-fixed 
E c~ G2 cells.  The specificity of the antiserum determined by the IFA is sum- 
marized in Table V. The lymphoid tissues of AKR/J mice absorbed the anti- 
body activity, whereas the tissues of C57BL/6J mice did not, although bone 
marrow  cells  and  spleen  cells of C57BL/6J  mice  occasionally showed  weak TABLE IV 
Specificity of Cell Surface Antigen Demonstrated with Rabbit Anti-FeLVp 30 Antiserum 
Re~idtml ~utibody  activity* 
Antigens  used for absorption  Dilution of absorbed serum  Result of  absorption 
1:1  1:2 
%  % 
AKR/J (2-too old) 
Spleen  17  11  -+- 
Thymus  35  21  + 
Lymph node  24  NT  + 
Bone marrow  < 10  < 10  + 
Liver  80  69  -- 
Kidney  76  61  -- 
Brain  78  63  -- 
Erythrocytes  80  NT  - 
--  86  77 
C57BL/6J(2-mo old) 
Spleen  81  64  -- 
Thymus  78  NT  -- 
Lymph node  82  NT  -- 
Bone marrow  61  43  ± 
Liver  80  62  -- 
Kidney  83  65  -- 
Brain  80  65  -- 
Erythrocytes  84  67  -- 
--  87  74  -- 
Tumors:~ 
C57BL/6 ECG2  <10  <10  -l- 
EL4  13  < 10  + 
C1498  48  35  + 
Balb/c  BALBCRLI  <I0  <i0  + 
MOPC-70A  76  65  -- 
AKR  K36  < 10  < 10  + 
SL  < i0  < I0  + 
--  84  68 
Cultured cells 
Uninfected rat fibroblasts 
RRTC cells producing Rauscher 
virus 
Uninfected feline fibroblasts 
Feline fibroblasts infected with FeLV 
Woolly monkey cells producing 
WMSV 
80  75  -- 
39  15  + 
81  77  -- 
<  10  NT  + 
80  74  -- 
93  79 
Viral proteins 
Sonicated MuLV 
Sonicated FeLV 
Sonicated SSV 
<10  <10  + 
24  15  + 
87  76  -- 
88  78 
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TABLE IV--Continued 
Antigens used for absorption 
Residual antibody activity* 
Dilution of absorbed serum 
1:1  1:2 
Result of 
absorption 
%  % 
Subviral proteins of MuLV prepared by 
gel filtration 
gp 45 (15 ~ug)§  71  57 
p 30 (15 #g)  <10  <10 
--  71  65 
+ 
gs antigen purified by isoelectric 
focusing 
MuLVp 30 (20 #g)  < 10  < 10 
FeLVp 30 (20/zg)  16  <10 
--  90  86 
+ 
+ 
Rabbit anti-FeLVp 30 antiserum was used at a serum dilution of 1  : 20. 
* % fluorescent-positive  cells. 
:~ see reference (14). 
§ Parentheses indicates/zg protein used for absorption. 
absorption.  RRTC  cells producing  Rauscher  virus  did  absorb  the  antibody 
activity. The antigen was not demonstrable in normal rat fibroblasts, in feline 
fibroblasts with or without infection by FeLV, or in woolly monkey tumor cells 
producing  woolly  monkey  sarcoma  virus.  Crude  viral  proteins  of  MuLV 
absorbed the antibody activity, whereas neither those of FeLV nor of SSV did 
so. Of six subviral proteins of MuLV prepared by gel filtration in GuHC1, only 
p  30 protein completely absorbed the antibody activity. The other five frac- 
tions were virtually negative for the absorption. These results were confirmed 
by the absorption test with p 30 protein of MuLV purified by isoelectric focus- 
ing which completely absorbed the antibody activity from rabbit anti-MuLVp 
30 antiserum, whereas purified p 30 protein of FeLV similarly prepared by iso- 
electric focusing did not absorb the antibody activity. These absorption data 
are consistent with the hypothesis that gs-1  antigenic determinant of MuLV 
is present on the surface of cells. It is to be noted that the fluorescence end point 
against viable Ec? G2 cells for the three gs-typing sera described above closely 
paralleled that against acetone-fixed E c? G2 cells. These collective observations 
virtually  excluded  the possibility  that  minor  contaminants  in  p  30 protein 
fraction had induced the antibody reacting against common cell surface anti- 
gen.  The antigen being detected on  the  cell surface with rabbit  anti-FeLV, 
rabbit  anti-FeLVp 30,  and rabbit  anti-Mu_LVp  30  antiserum was  concluded 
to be, and was given the designation, membrane-bound gs antigen. 
Location of Membrane-Bound  gs Antigen.--In  our previous report, the loca- 
tion of common cell surface antigen was demonstrated solely on the cell surface TABLE V 
Demonstration  of gs-I Antigen of MuLV on the Surface of Cells 
Antigens used  for absorption 
Residual antibody activity* 
Dilution of absorbed  serum 
1:1  1:2 
Result of 
absorption 
AKR/J (2-too old) 
Spleen 
Thymus 
Lymph node 
Bone marrow 
Liver 
Kidney 
Brain 
Erythrocytes 
<10%  NT  q- 
28  13  + 
NT  < 10  + 
<10  <10  + 
73  56  - 
70  NT  -- 
73  58  - 
71  57  - 
80  62 
C57BL/6J(2-mo old) 
Spleen 
Thymus 
Lymph node 
Bone marrow 
Brain 
82  75 
83  NT 
80  NT 
82  73 
81  70 
86  79 
m 
m 
m 
Cultured ceils 
Uninfected rat fibroblasts 
RRTC cells producing Rauscher virus 
Uninfected feline fibroblasts 
Feline fibroblasts infected with FeLV 
Woolly monkey ceils producing WMSV 
83  NT  -- 
13  NT  -4- 
82  74  -- 
NT  71  -- 
76  69  -- 
88  77 
Viral proteins 
Sonicated MuLV  <10  <10 
Sonicated FeLV  77  73 
Sonicated SSV  76  71 
--  79  72 
+ 
Subviral proteins of MuLV prepared by 
gel filtration 
gp 45  (50/zg)  77  70 
gp 70 (40/zg)  75  69 
p 30 (20/~g)  <10  <10 
p 15  (30 #g)  79  69 
p  12  (20/zg)  78  66 
p  10 (30/zg)  79  67 
--  78  67 
+ 
gs antigen purified by isoelectric focusing 
MuLVp 30  (20/zg)  <10  <10 
FeLVp 30  (20 #g)  79  71 
--  84  73 
+ 
Rabbit anti-MuLVp 30 antiserum was used at a serum dilution of 1:160. 
* %  fluorescent positive ceils. 
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but not on the viral envelope by immunoelectron microscopy (14). We con- 
firmed and extended this observation by using rabbit anti-FeLVp 30 and anti- 
MuLVp 30 antiserum. Several descrete areas of attached ferritin were observed 
on the cell surface of E c~G2 that had been incubated with  absorbed rabbit 
anti-FeLVp 30 antiserum diluted to 1:5. In contrast, no ferritin labeling was 
observed on the viral envelopes of C-type RNA viruses (Fig.  1 a  and b).  Cell 
surface labeling of E cPG2 cells  that were similarly treated with rabbit  anti- 
FeLV antiserum was used as positive control (Figure 1 c). It is of interest that 
ferritin labeling was  frequently observed near the  site of virus  budding,  al- 
though viral envelopes were not labeled. The same pattern of ferritin labeling 
was observed with rabbit anti-MuLVp 30 antiserum, although the cell surface 
labeling was usually wider in extent than that noted with rabbit anti-FeLVp 30 
antiserum  (figure not presented). Negative controls using either medium  199 
instead of antiserum or C57BL/6J thymocytes instead of Ec?G2 cells as target 
cells were virtually unlabeled. 
Intracytoplasmic  Location of gs Antigen.--The  intracytoplasmic location of 
gs  antigen  was  examined  on  cryostat sections  of  C57BL/6J  mouse  spleens 
bearing E cV G2 transplant by the indirect immunofluorescence test as described 
in the Materials and Methods. Bright granular fluorescence was observed in the 
cytoplasm of E cPG2 cells after being incubated with rabbit  anti-MuLVp 30 
antiserum (Fig. 2 a). No nuclear fluorescence was observed. The specificity of 
the  reaction was  confirmed by specific absorption  with purified MuLVp  30 
protein prepared by isoelectric focusing (Fig. 2 b). The section treated with PBS 
instead of antiserum was virtually unstained (Figure 2 c). The same pattern of 
fuorescence was  observed  with  rabbit  anti-FeLVp  30  antiserum  (not  pre- 
sented). These observations are consistent with the results reported by others 
(4, 21, 22) that gs antigen is located in the cytoplasm of cells. 
Some Biological Properties of Membrane-Bound gs Antigen.--Although  mem- 
brane-bound gs antigen was detected by the IFA on the thymocytes of AKR/J 
mice at 2 mo of age, the indirect membrane immunofluorescence test was vir- 
tually negative against those thymocytes. It was of interest to examine whether 
membrane-bound gs antigen increased in amount with aging and particularly 
with the development of thymic leukemia. The summary of the indirect mem- 
brane immunofluorescence test of thymocytes of AKR/J and C57BL/6J mice 
with rabbit anti-FeLV antiserum is shown in Fig. 3. The thymocytes of AKR/J 
mice  at  2-5  mo  of  age  showed very weak or negative membrane immuno- 
fluorescence reaction with rabbit anti-FeLV antiserum. With the development 
of leukemia, the percent fluorescent-positive cells  as well  as  the  intensity of 
fluorescence were markedly increased. The fluorescent-positive cells were mostly 
large-size leukemia cells.  The thymocytes of C57BL/6J mice were invariably 
negative for the membrane fluorescence reaction with rabbit anti-FeLV anti- 
serum over the same age-range studied. Fro.  I.  Ec~G2 cells were reacted with rabbit anti-FeLVp 30 antiserum followed by ferritin- 
labeled sheep antibody to rabbit ~/-globulin (a and b). E~G2  cells were reacted with rabbit 
anti-FeLV  antiserum  and  then  treated  with  ferritin-conjugated  goat  antibody  to  rabbit 
"y-globulin (c). Several sectors on the cell surface were labeled with ferritin, indicating mem- 
brane-bound gs antigen-positive sites, but the envelopes of budding viruses were not labeled at 
all. a and b, X  140,000  and c X  120,000. 
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FIG.  2.  Frozen section of C57BL/6J mouse spleen bearing Eo~G2 transplant was reacted 
with (a)  rabbit anti-MuLVp 30,  (b)  rabbit anti-MuLVp 30 antiserum absorbed with purified 
MuLVp  30  protein,  (c)  PBS,  and  followed  by fluorescein-labeled  goat antibody  to  rabbit 
3,-globulin.  Bright granular fluorescence  was observed in the cytoplasm of C57BL/6J mouse 
spleen bearing Eo~G2 transplant but nuclei are not stained at all (a). The specific absorption 
of the fluorescence  reaction was observed (b). PBS control was virtually unstained  (c).  X  500. 
._~  5o 
100  m 
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•  Nonleukemic  AKRtJ 
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Ao  •  Ao  •  •  •  •  • 
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FIG. 3.  Indirect  membrane  immunofluorescence reaction  of  thymocytes  of AKR/J and 
C57BL/6J mice. Thymocytes of AKR/J and  C57BL/6J mice at various ages were reacted 
with  rabbit  anti-FeLV antiserum  followed  by  fluorescein-labeled  goat  antibody  to  rabbit 
3,-globulin.  Reactions were graded as follows:  >50% fluorescent cells,  strong positive; 50%- 
10% fluorescent ceils, weak positive; <10% fluorescent cells, negative. YOSHIKI, MELLORS~ HARDY, AND  FLEISSNER  939 
DISCUSSION 
Several observations presented in this paper lead to the conclusion that gs 
antigen,  the  major  internal  structural  protein  of  mammalian  C-type  RNA 
viruses,  is present  on  the  surface of cells infected or  transformed by mam- 
malian C-type viruses. Since we also confirmed that gs antigen is located in the 
cytoplasm of such cells,  in keeping with the observations described by others 
(4,  21, 22), it is reasonable to conclude that gs antigen is located both in the 
cytoplasm and on the surface of cells. The biological properties of membrane- 
hound gs antigen are unknown at the present time. However, there are several 
possibilities to  consider,  among  them  are  the  following:  (a)  gs  antigen may 
adsorb to the cell surface in a manner similar to that described for other soluble 
antigens associated with murine C-type RNA viruses; (b) gs antigen may re- 
main on or in the cell surface after attachment and entering of cells by C-type 
RNA viruses; (c) gs antigen may appear on the cell surface after being synthe- 
sized in the cytoplasm of cells; and (d) membrane-bound gs antigen may have 
some active function relating to virus output from the surface of cells or to some 
other aspect of the life cycle of the virus. 
Stiick et al. (23) and Aoki et al.  (24) demonstrated by either the cytotoxic or 
the  indirect  membrane  immunofluorescence  test  that  the  soluble  antigens 
associated with murine C-type RNA viruses adsorb on to the cell membrane in 
vitro, although it is not known whether this phenomenon occurs in vivo. Since 
gs antigen of C-type RNA viruses has been demonstrated in the serum and the 
plasma of mice and cats, probably owing to the presence of viremia, membrane- 
bound gs antigen might derive from the adsorption of gs antigen on the surface 
of cells. In our recent studies, however, neither C1498 leukemia cells, which can 
adsorb Gross soluble antigen on their cell surface, nor C57BL/6J thymocytes 
showed any increased or positive membrane immunofluorescence reaction with 
gs-typing sera after being incubated in vitro with ether-disrupted MuLV and 
FeLV which contained large amount of gs antigen. Furthermore, the patchy- 
ring pattern of the indirect membrane immunofluorescence reaction of E c~ G2 
cells that had been reacted at 4°C with rabbit anti-FeLV and MuLVp 30 anti- 
sera followed by fluoresceinated goat antibody to rabbit 7S ~,-globulin  became 
capped in appearance after the cells were incubated at 37°C for 5 min (Yoshiki 
and  Mellors,  unpublished  observation). These observations indicate  that  gs 
antigen is indeed integrated into the molecular arrays of the fuid mosaic of the 
cell membrane (25). 
Miyamoto and Gilden (26) reported in their electron microscopic studies of 
the entry of MuLV into cultured cells that viral nncleoids sometimes remained 
on the cell surface after the dissolution of viral envelopes. In our present im- 
munoelectron  microscopic  studies,  viral  nucleoid-like  materials  were  not 
observed at the site of membrane-bound gs antigen labeled by ferritin. 
Hilgers et ai.  (27)  reported that the amount of gs antigen in the leukemic 
thymus of AKR mice was greatly increased in comparison with the nonleukemic 
thymus of AKR mice. Rowe et al.  (28) found that the infectious MuLV titers 940  CELL  MEMBRANE-BOUND  gs  ANTIGEN 
in the leukemic thymus of AKR mice were markedly increased over those of 
nonleukemic mice and suggested that the undifferentiated malignant cells have 
a  greater  capacity to produce infectious virus  than do normal  thymocytes, 
although a high proportion of cells are infected in both the normal and lympho- 
matous  thymus.  Our  indirect  membrane  immunofluorescence  reaction  of 
membrane-bound gs antigen on the thymocytes of AKR/J mice showed that 
percent fuorescent-positive cells of the leukemic thymus were greatly increased 
compared  to  those of  the  nonleukemic thymus.  It  is  to  be  noted  that  the 
fluorescent-positive cells were mainly large-size  leukemia cells. In addition, we 
observed by immunoelectron microscopic studies that the cell surface location 
of membrane-bound gs antigen frequently was near the site of virus budding, 
although the viral envelope was not labeled at all. Those observations lead us 
to propose  that membrane-bound gs antigen may have important biological 
functions relating to virus assembly and maturation near and at the surface of 
cells or relating to other steps of incipient virus synthesis. Further investiga- 
tions are necessary to clarify this point. 
Parks and Scolnick (29) reported that interspecies gs-3  antigen was found 
in the primate C-type RNA viruses by radioimmunoassay. However, in order 
to demonstrate "displacement" of labeled MuLV gs antigen by the primate gs 
antigen, 10-fold more primate than routine viral protein had to be added to the 
reaction to give a comparable displacement. Furthermore, under the conditions 
used primate gs antigen did not displace all of the antibody against murine gs 
antigen.  Recently,  Sch~fer  et  al.  (30)  reported  comparable  observations  in 
comparative studies using the Ouchterlony test. Our negative absorption data 
obtained with woolly monkey cells producing woolly monkey sarcoma virus 
and with crude viral protein of SSV may be conceivably explained either by a 
lower sensitivity of our assay method employed or by quantitative differences 
in the amount of antigen used for the absorption test. 
Our  characterization of membrane-bound gs  antigen as  a  cell  membrane- 
integrated internal protein of mammalian (murine and feline)  C-type RNA 
viruses opens up new possibilities for the study of C-type virus expression and 
virus-cell relationship. 
SUMMARY 
The indirect membrane immunofluorescence test and the absorption analysis 
of rabbit  anti-FeLV, rabbit anti-FeLVp 30,  and rabbit anti-MuLVp 30  anti- 
sera  yielded  the  following  conclusions.  An  antigen  shared  by  mammalian 
(murine and feline) C-type RNA leukemia and sarcoma viruses was detected 
on the surface of cells infected or transformed by C-type viruses. The antigen 
was characterized as membrane-bound gs antigen bearing two determinants, 
membrane-bound  gs-1,  intraspecies-specific antigenic determinant, and mem- 
brane-bound  gs-3,  interspecies-specific  antigenic  determinant.  Membrane- 
bound gs antigen was located on the cell surface, frequently near the site of 
virus budding but not on the envelope of murine C-type RNA virus. YOSHIKI, MELLORS, HARDY, AND ~'LEISSNER  941 
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